Gkretsi et al. [33] showed that silencing of VASP in MDA-MB-231 cells inhibited tumor spheroid invasion by downregulating the expression of migfilin, β-linked protein, and urokinase-fibrinogen activator, and that high VASP expression was associated with poor remission-free survival in lymph node-positive BC patients. The gene discussed is VASP; the disease is neoplasm.